Clinical trial
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the…
NCT00221000 · Mallinckrodt, Industry · Completed
Key facts
| NCT number | NCT00221000 |
|---|---|
| Title | Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis |
| Official title | A Phase II, Multicenter, Randomized, Double-blind, "Sham" Pheresis-controlled, Study of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis in Patients Who Have an Inadequate Response to Disease Modifying Antirheumatic Drugs and Biological Agents |
| Acronym | RA-1 |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug, Procedure |
| Interventions | Methoxsalen, Extracorporeal Photopheresis |
| Enrollment | 86 |
| Start date | Aug 1, 2003 |
| Primary completion | Oct 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 19, 2016 |
| Countries | Australia, Austria, Belgium, Canada, France, Germany, Italy, Mexico, Slovakia, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: